Progressive Supranuclear Palsy
Progressive Supranuclear Palsy (PSP) is a degenerative neurologic condition that affects brain functions such as mobility, speech, and cognition. Many patients who actually have PSP are misdiagnosed as having Parkinson's disease, Alzheimer's disease, or vascular disease (stroke), but as symptoms evolve, the condition can be recognized.
PSP is less common than Parkinson's and Alzheimer's diseases, which means there is far less research into PSP. As such, there is currently no approved treatment for the symptoms of PSP, and nothing has been found to slow the rate of disease progression.
What UTSW Can Do
UT Southwestern has the scientific and clinical capacity and the referral base to make advances in PSP. We have formed a team to:
- Study the disease
- Provide clinical care for people with PSP
- Research cures and symptomatic treatments
- Collaborate and share knowledge with colleagues throughout the country and around the world
- Educate patients, families, caregivers, physicians, and the community about this disease
Our mission is to lessen the burden of this disease as much as possible for as many patients as possible.
By working with patients, caregivers, clinicians, and researchers and tracking outcomes, together, we can:
- Learn what treatments can relieve symptoms
- Apply systematic continuous improvement processes
- Test the efficacy of potential disease modifying treatments, based on a rapidly advancing understanding of the disease mechanism.
Together, we can make real progress.
To each patient, we vow to:
- Show compassion for each person affected directly and indirectly by PSP
- Understand the patients' needs are primary
- Carefully apply the best practices and data-driven continuous improvement processes
- Apply intellectual curiosity to understand and undo the pathologies of PSP